A shared framework for very different cancers
The hallmarks of cancer, introduced by Hanahan and Weinberg, organize the bewildering diversity of tumors into a small set of capabilities a normal cell must acquire to become malignant. These include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis. The framework lets researchers compare cancers by the capabilities they share rather than by tissue of origin.
Later updates added emerging hallmarks and enabling characteristics, notably reprogrammed energy metabolism and avoiding immune destruction, plus the enabling traits of genome instability and tumor-promoting inflammation. The point is that no single mutation makes a cancer; a cell must collect several of these capabilities, usually over time.
Why the framework guides therapy design
Each hallmark suggests a therapeutic target. Drugs that block angiogenesis, that release immune cells against the tumor, or that exploit defective DNA repair all map onto specific hallmarks. Reading cancer through this lens helps explain why combination strategies, attacking more than one capability, tend to be more durable than hitting a single pathway.
How to use this overview
This is general educational information about cancer biology, not medical advice. The hallmarks are a conceptual model; real tumors vary in which capabilities dominate, and treatment decisions depend on the specific cancer and patient.